Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 6/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | PRKCI | P41743 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10066339 | 0.85 | CA5A (0.50) | CA5ALMNACYP2A6HSD17B1MAPT | |
| SCHEMBL12659328 | 0.84 | NPC1 (0.45) | CA5ALMNACYP2A6HSD17B1RAB9A | |
| SCHEMBL6377610 | 0.81 | CA5A (0.50) | CA5ALMNACYP2A6FFAR4HSD17B1 | |
| SCHEMBL1644952 | 0.81 | CA5A (0.56) | CA5ALMNAHSD17B1RAB9ANPC1 | |
| SCHEMBL801824 | 0.80 | LMNA (0.62) | CA5ALMNARAB9ACYP3A4KMT2A | |
| SCHEMBL12399061 | 0.80 | SMN1; SMN2 (0.46) | LMNANPC1MAPTSMN1; SMN2KMT2A | |
| SCHEMBL12983073 | 0.79 | CA5A (0.48) | CA5ALMNACYP2A6FFAR4HSD17B1 | |
| SCHEMBL2786636 | 0.79 | CYP3A4 (0.50) | CA5ALMNACYP2A6FFAR4HSD17B1 | |
| SCHEMBL8058634 | 0.79 | CA5A (0.48) | CA5ALMNACYP2A6HSD17B1RAB9A | |
| SCHEMBL16769478 | 0.79 | CA5A (0.48) | CA5ALMNACYP2A6FFAR4HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11912736-B2 | Diaryl trehalose compounds and uses thereof | THE UNIVERSITY OF MONTANA (US) | 2024-02-27 | — | — | US | disclosed |
| US-20170349561-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | UNITED STATES DEPARTMENT OF ENERGY | 2017-12-07 | — | — | US | disclosed |
| US-9765044-B2 | Synthesis of novel ionic liquids from lignin-derived compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-09-19 | — | — | US | disclosed |
| US-20170183312-A1 | HERBICIDAL SUBSTITUTED 3-ARYLPYRAZOLES | FMC CORPORATION | 2017-06-29 | — | — | US | disclosed |
| US-9562044-B2 | 2-acylaminothiazole derivative or salt thereof | ASTELLAS PHARMA INC. (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20170008922-A1 | BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND | AJINOMOTO CO., INC. (JP) | 2017-01-12 | — | — | US | disclosed |
| US-9371353-B2 | Oligonucleotide with protected base | AJINOMOTO CO., INC. (JP) | 2016-06-21 | — | — | US | disclosed |
| US-20160031843-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | UNITED STATES DEPARTMENT OF ENERGY | 2016-02-04 | — | — | US | disclosed |
| US-20160002218-A1 | 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF | ASTELLAS PHARMA INC. (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20150080565-A1 | OLIGONUCLEOTIDE WITH PROTECTED BASE | AJINOMOTO CO., INC. (JP) | 2015-03-19 | — | — | US | disclosed |
| EP-0153904-B1 | PROCESS FOR THE PREPARATION OF A PROTECTION LAYER OR A RELIEF PATTERN | CIBA-GEIGY AG (CH) | 1988-09-14 | — | — | EP | disclosed |
| EP-0152377-B1 | CURABLE COMPOSITIONS AND THEIR USE | CIBA-GEIGY AG (CH) | 1987-12-09 | — | — | EP | disclosed |
| US-4624912-A | EXPOSURE TO ELECTRON OR ACTINIC RADIATION, THEN HEATING | CIBA-GEIGY CORPORATION (US) | 1986-11-25 | — | — | US | disclosed |
| EP-0153904-A2 | Process for the preparation of a protection layer or a relief pattern | CIBA-GEIGY AG (CH) | 1985-09-04 | — | — | EP | disclosed |
| EP-0152377-A2 | Curable compositions and their use | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | disclosed |
| US-4229274-A | PHOTOINITIATOR, PHOTOSENSITIZER, QUENCHER, AND COMPOUNDS CONTAINING ACRYLYLOXY GROUPS | PPG INDUSTRIES, INC. (US) | 1980-10-21 | — | — | US | disclosed |
| US-4070499-A | Method for crosslinking ultraviolet light curable coatings | PPG INDUSTRIES, INC. (US) | 1978-01-24 | — | — | US | disclosed |
| US-4037112-A | Apparatus for crosslinking ultraviolet light curable coatings | PPG INDUSTRIES, INC. (US) | 1977-07-19 | — | — | US | disclosed |
| US-4024296-A | Photocatalyst system and pigmented actinic light polymerizable coating compositions containing the same | PPG INDUSTRIES, INC. (US) | 1977-05-17 | — | — | US | disclosed |
| US-4017652-A | Photocatalyst system and ultraviolet light curable coating compositions containing the same | PPG INDUSTRIES, INC. (US) | 1977-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160031843-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | DCXR, LCT, LARS1 | CA5A 2558/4885LMNA 128/4885CYP2A6 4629/4885 |
| US-20160002218-A1 | 2-ACYLAMINOTHIAZOLE DERIVATIVE OR SALT THEREOF | CHRM3, CHRM2, CHRM5 | CA5A 1000/4885LMNA 4251/4885CYP2A6 4145/4885 |
| US-20150080565-A1 | OLIGONUCLEOTIDE WITH PROTECTED BASE | POLRMT, POLN, RNGTT | CA5A 2058/4885LMNA 712/4885CYP2A6 4508/4885 |
| US-20170008922-A1 | BRANCHED CHAIN-CONTAINING AROMATIC COMPOUND | VIP, IAPP, BCAT1 | CA5A 2645/4885LMNA 2252/4885CYP2A6 3191/4885 |
| US-20170183312-A1 | HERBICIDAL SUBSTITUTED 3-ARYLPYRAZOLES | CYP1B1, CYP1A1, TYR | CA5A 243/4885LMNA 3763/4885CYP2A6 178/4885 |
| US-20170349561-A1 | SYNTHESIS OF NOVEL IONIC LIQUIDS FROM LIGNIN-DERIVED COMPOUNDS | LSS, DCXR, MYB | CA5A 4026/4885LMNA 101/4885CYP2A6 3726/4885 |
| US-11912736-B2 | Diaryl trehalose compounds and uses thereof | TREH, STT3B, DDOST | CA5A 2333/4885LMNA 4611/4885CYP2A6 4149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.